Entero Healthcare Solutions
ENTERONSE

Entero Healthcare Solutions

₹1,418.10103.00 (7.83%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,328.30
Today’s high
1,419.90
52 week low
944.00
52 week high
1,426.30
Open price
1,363.90
Previous close
1,315.10
Live volume
2,90,725
Lower circuit
1,052.10
Upper circuit
1,578.10

Fundamentals

Market Cap
₹5,725Cr
ROE
6.81%
P/E Ratio(TTM)
34.15
EPS(TTM)
38.52
P/B Ratio
3.40
Dividend Yield
0.00%
Industry P/E
37.16
Book Value
386.51
Debt to Equity
0.40
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹1,944
+1.54%
Profit (Cr)
₹52.05
+15.33%
0156.36251.41k2.5k
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+38%
3Y CAGR+26%
Profit growthValue
1Y (TTM)+72%
3Y CAGR+147%

About

Entero Healthcare Solutions Limited is a technology-driven healthcare supply chain aggregator, distributing pharmaceutical and healthcare products to pharmacies, hospitals, and clinics.;
CEO/MD
Prabhat Agrawal
Founded in
2018
NSE symbol
ENTERO

Shareholding Pattern

Jun '26
Mar '26
Dec '25
Sep '25
Jun '25
Promoters
52.42%
Retail And Others
20.19%
Foreign Institutions
17.20%
Mutual Funds
6.14%
Other Domestic Institutions
4.05%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹98.31
0.00 (--)
L
    H
    7,102.41098.47
    ₹889.95
    -6.75 (0.75%)
    L
      H
      5,975.1918.372.95
      ₹309.50
      +0.80 (0.26%)
      L
        H
        2,386.1881.2426.35
        ₹363.00
        +1.95 (0.54%)
        L
          H
          1,119.5032.016.05
          Livesquawk
          Entero Healthcare Solutions Q1 revenue rises to ₹19.4B from ₹14B YoY. The company demonstrates strong year-over-year growth in revenue.
          Livesquawk
          Jefferies maintains Buy on Entero Healthcare Solutions, raising TP to ₹1500 citing 23% FY27 organic growth. Higher tax and depreciation trim FY27 EPS, but 100 bps EBITDA margin expansion supports positive outlook.
          2026
          7
          Aug
          Quarterly Result
          Release date
          25
          May
          Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks